A group of systemic autoimmune diseases, including systemic lupus erythematosus (SLE),' scleroderma, Sjogren's syndrome, dermatomyositis/polymyositis, and mixed connective tissue disease (MCTD) , are characterized by a distinctive immune response which is manifested as the spontaneous production ofautoantibodies that react with intracellular proteins and nucleic acids (reviewed in reference 1). A finding that has had an important impact on clinical medicine has been the demonstration that each ofthe diseases described above has its own individual set of autoantibodies, so that autoantibody profiles have been useful in differential diagnosis. In molecular and cell biology, autoantibodies have been used to clarify the molecular structure ofintracellular molecules and their role in the biological function of important intracellular processes. The interactions between clinical and basic sciences in this field of research have been especially active in the past decade and are a good example of bridges being built between these disciplines.
Most of the earlier studies on autoantibodies focused on those reactive with DNA and nucleoproteins, the latter now recognized as the histone components ofdeoxyribonucleoprotein. These studies demonstrated the important role of autoantibody to DNA in the pathogenesis of tissue inflammation via immune complex formation (2, 3) and stimulated continued investigations into the relationship of autoantibodies with disease mechanisms. A nonhistone nuclear protein antigen called Sm was defined in 1966 by immunoprecipitation in agarose gel double diffusion analysis (4) . The Sm antigen was shown to be a protein that was nuclear in location and antibodies were found to be highly specific for SLE. Shortly thereafter, another nuclear antigen was identified with antibodies present in sera of patients with lupus and MCTD, and since immunological studies showed that integrity ofboth RNA and 1. Abbreviations used in this paper: CREST, calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia; MCTD, mixed connective tissue disease; PCNA, proliferating cell nuclear antigen; pre mRNA, precursor mRNA; RNP, ribonucleoprotein; SLE, systemic lupus erythematosus; snRNP, small nuclear RNP; U, uridylate-rich.
protein was required for antigenicity, the antigen was designated nuclear ribonucleoprotein (RNP) (5, 6) . In addition to cell fractionation experiments, immunofluorescence helped to confirm the nuclear location of both antigens. When isolated from homogenized cell preparations, the two antigens were shown to be in close physical association, with the nuclear RNP antigen appearing to be always coisolated with Sm, but with a fraction of Sm that could be isolated free of nuclear RNP antigen (5-7).
Autoantibodies in molecular and cell biology It is of interest but perhaps coincidental that the molecular structures of these two antigens were the first nuclear nonhistone protein antigens to be defined (Table I) . Lerner and Steitz (8) showed that the Sm and nuclear RNP antigens were RNP particles that were complexes of small nuclear RNAs, called uridylate-rich (U) RNAs, and different proteins. These RNAprotein particles have been called small nuclear RNPs (snRNPs) and they comprise a large family, but ofrelevance to autoimmunity are the U I to U6 snRNPs. The U RNA components of snRNPs are small RNAs and, with the exception of U6, have distinctive 5'-termini consisting of trimethyl guanosine cap structures (for review see reference 9). What were defined immunologically as the Sm antigens are four core proteins of snRNP particles with molecular masses of 29 (B'), 28 (B), 16 (D), and 13 (E) kD and perhaps two smaller proteins of 12 and 11 kD. These core proteins are intrinsic components of U 1, U2, U4, U5, and U6 snRNPs and are the reason why antibody of the Sm specificity coprecipitates the associated U RNAs together with the core proteins. On the other hand, the antibody from lupus and MCTD, which had been designated antinuclear RNP, recognizes two proteins of 33 (A) and 22 (C) kD, which are distinctive components of U 1 RNP and are not present in other U RNP species. Hence, antibody of nuclear RNP specificity only coprecipitates U1 RNA but not U2 or other RNAs. It is seen from Table I that anti-U 1 RNP is also reactive with a 70-kD protein that has been shown to be associated with the nuclear matrix (10) and is therefore not an intrinsic protein of snRNPs.
It can be seen from this briefdiscussion that autoantibodies of anti-Sm and anti-nuclear RNP specificities have been instrumental in elucidating the molecular structure of snRNP particles, especially the core protein molecules of all particles and distinctive proteins associated with individual species. In addition, autoantibodies have been used as invaluable reagents to probe the function of snRNPs and these studies have led to important advances in the understanding of precursor RNA (pre mRNA) splicing. It was noticed that there was striking base pairing capability between the 5' end of U1 RNA and intron splice junctions, leading to the proposal that U 1 snRNP could be playing a role in this process (1 1, 12) . The stepwise (Table I) . SS-B/La is a ubiquitous nuclear protein of 48 kD which is an antigen recognized by autoantibodies in sera of patients with SLE and Sjogren's syndrome (18, 19) . The antigen SS-B was shown to be transiently associated with RNA polymerase III transcripts and it was presumed to have a role in the maturation ofcertain precursor RNAs, including tRNA, 5S RNA, 4.5S RNA, and 7S RNA (20) (21) (22) . Recently it was demonstrated that SS-B/La was required for termination of RNA polymerase III transcription (23) . However, questions that remain to be elucidated include reasons for its close physical association with the SS-A/Ro antigen (see reference 1) and what role the latter contributes to the process.
Proliferating cell nuclear antigen (PCNA) is a nuclear protein of 36 kD that was first identified with autoantibody present in -3% of lupus patients (24) . A unique feature observed in the first study was that immunolocalization ofthe antigen in cell nuclei varied in intensity and configuration, and this was shown to be related to the proliferative state of the cell, with actively proliferating cells containing antigen detectable by immunofluorescence in contrast to weak or negative immunofluorescence in quiescent cells. There is a recent comprehensive review of this subject (25) that describes the sequence of studies showing the identity of PCNA with cyclin (26) and the auxiliary protein ofDNA polymerase delta (27) . Autoantibody to PCNA has been a key reagent in elucidating the mechanism of DNA replication regulated by DNA polymerase delta. In SV40 replication, PCNA is required for leading strand (continuous) but not for lagging strand (discontinuous) DNA synthesis (28). This effect is reported to be due to PCNA reversing an inhibitor that blocks the elongation reaction of SV40 DNA replication (29) . When autoantibody was microinjected into eggs ofXenopus laevis, the relative contributions ofDNA polymerases a and a to replication ofintrinsic egg chromosomes or injected plasmid pUC9 DNA could be analyzed (30). With the convergence of technologies and interests in the fields of immunology, biochemistry, and molecular and cell biology, it has been stated that the study of PCNA may serve as a paradigm for proteins that participate in replication or cell cycle events (25) .
Biologists engaged in the study of cell events related to mitosis were highly interested in the identification ofautoantibodies to centromeric proteins in the sera of patients with the CREST (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) variant of scleroderma (31) . These autoantibodies reacted with proteins of 17, 80, and 140 kD (32) (33) (34) that were tightly associated with centromeric DNA and were components of the kinetochore, a trilaminar structure demonstrable by electron microscopy and to which spindle fibers attach during daughter chromatid separation at mitosis. Kinetochore structures that had not been detected previously in the cell nucleus during interphase could now be easily identified with antibodies, and their existence in the interphase nucleus was established (31, 35) . It was also demonstrated that duplication of kinetochores during mitosis could be pinpointed to G2, the cell-cycle phase after DNA replication (35 The immunogen is a subcellular particle It is not possible to describe in detail here the great diversity of autoantibodies that have been identified and the corresponding antigens that have been characterized (see reference 1 for review), but certain distinctive features need to be emphasized. Certain autoantibodies are highly specific for a particular disease and they include anti-Sm and anti-native DNA for lupus, anti-tRNAHisThra synthetases for polymyositis, anti-Scl-70 for diffuse scleroderma, and anti-centromere/kinetochore for CREST. Antibodies of these specificities are rarely detected in other diseases. In addition to individual autoantibody specificity, there is group specificity which is manifested as autoantibodies that tend to be associated in unusual frequency with each other, and these antibody groupings can be recognized as distinct antibody profiles. In lupus, these profiles include the common association of anti-Sm with anti-U1 RNP, whereas in MCTD anti-U1 RNP is present without anti-Sm. In Sjogren's syndrome, anti-SS-A/Ro and anti-SS-B/La are present together without other recognizable autoantibodies, whereas these autoantibodies are also present in lupus but frequently in association with other antibodies such as anti-native DNA and anti-Sm. In scleroderma (Table II) , the major antigen-antibody systems are anti-Scl-70 (DNA topoisomerase I) and anti-centromere antibodies. Several studies have shown that autoantibodies ofthese two specificities seldom occur simultaneously in the same patient, and anti-Scl-70 appears to be associated with the diffuse form of scleroderma, whereas anticentromere is associated with CREST (1). In addition, there are other defined autoantibodies that occur in lower frequency but appear to be highly specific for scleroderma.
The new information on the molecular identity of autoantigens suggests that in vivo immunogens might be subcellular particles and not individual proteins. The Sm immune response is directed against at least four proteins, the B', B, D, and E core proteins of snRNP particles. Anti-U1 RNP immune response is directed against the A and C proteins of the Ul RNP particle and also the 70-kD protein, which is not in the family ofsnRNPs but as described earlier may be a nuclear matrix protein associated with Ul RNP. The autoantibody profile in scleroderma may be particularly revealing in that the antigens RNA pol I, fibrillarin, PM-Scl, To, and NOR-90 are all nucleolar in location or predominantly so and DNA topoisomerase I (Scl-70), which is a DNA supercoil relaxing enzyme, has been shown to be in the nucleolus associated with ribosomal DNA transcription centers (59) and in nucleolar organizer regions (60) . The evidence that the immunogen in vivo might be subcellular particles or molecules coexisting in structurally distinct cellular compartments could account for the occurrence of autoantibodies directed against several different proteins, which is so characteristic of this group of diseases.
Autoepitopes are active sites, catalytic centers, or functioning regions An important effort in autoimmunity research has been directed at defining the autoepitopes on protein antigens. In Table II (65, 66) . Autoantibodies to tRNA synthetases were identified by their ability to inhibit aminoacylation of the cognate tRNAs (67) and autoantibody to RNA polymerase I inhibited 28S and 18S RNA synthesis when microinjected into Xenopus laevis oocytes (68). The special significance of these observations was brought into focus when studies showed that autoantibodies, in contrast to experimentally induced heterologous immune sera, had the special capability to inhibit function, whereas most heterologous antisera did not have this property. Autoantibody to PCNA (from lupus patients) inhibited an in vitro assay simulating DNA replication (69), whereas experimentally-induced antisera consisting of two murine MAbs and a rabbit antipeptide immune serum were without effect. Similarly, human autoantibody inhibited threonyl-tRNA synthetase activity, whereas rabbit polyclonal antibody to the purified protein did not (70) . These (7 1) and from mercuric chloride-treated mice and rats where autoantibodies to the nucleolar antigen fibrillarin have been identified (72, 73) .
